by Perelman School of Medicine at the University of Pennsylvania Image of a CAR T cell. Credit: Penn Medicine Chimeric antigen receptor (CAR) T cell therapy, which uses engineered T cells to treat certain types of cancers, has often been a challenging approach to treating solid tumors. CAR T cells need to recognize a specific target...
